RAGE在激光诱导脉络膜新生血管的视网膜下纤维化中必不可少:治疗意义
该研究在雄性RAGE基因敲除小鼠与野生型小鼠中通过激光光凝诱导视网膜下纤维化,第35天评估纤维化体积;并在原代人视网膜色素上皮细胞中用转化生长因子-β2诱导上皮-间质转化。结果显示RAGE缺失减轻小鼠视网膜下纤维化,RAGE拮抗剂FPS-ZM1或阿泽利拉贡抑制人视网膜色素上皮细胞的上皮-间质转化,提示RAGE是视网膜下纤维化的潜在治疗靶点。
要点
- RAGE敲除小鼠激光诱导脉络膜新生血管后视网膜下纤维化体积较野生型小鼠显著减小。
- RAGE拮抗剂FPS-ZM1或阿泽利拉贡可抑制转化生长因子-β2诱导的人视网膜色素上皮细胞上皮-间质转化。
- FPS-ZM1阻断转化生长因子-β2诱导的Smad2依赖性信号通路和上皮-间质转化,不影响细胞外信号调节激酶通路。
核心结论
- RAGE参与视网膜下纤维化中视网膜色素上皮细胞的上皮-间质转化,RAGE拮抗剂可减弱该过程,使RAGE成为新生血管性年龄相关性黄斑变性视网膜下纤维化的有前景治疗靶点。
研究设计与样本
- 在雄性RAGE基因敲除小鼠和野生型小鼠中通过激光光凝诱导视网膜下纤维化,第35天用光学相干断层扫描和免疫染色评估纤维化病灶体积。
- 体外用转化生长因子-β2诱导原代人视网膜色素上皮细胞上皮-间质转化,细胞先用RAGE拮抗剂FPS-ZM1或阿泽利拉贡预处理,再与转化生长因子-β2共处理48小时。
- 信号研究采用FPS-ZM1预处理2小时、与转化生长因子-β2共处理60分钟后进行免疫印迹分析。
主要发现
- 与野生型小鼠相比,RAGE敲除小鼠激光诱导脉络膜新生血管后视网膜下纤维化显著减轻,纤维化体积更小、炎症更少、pSmad2活化降低、纤维化标志物(αSMA、I型胶原)沉积减少。
- 在人视网膜色素上皮细胞中,转化生长因子-β2处理增加线粒体活性氧并上调上皮-间质转化标志物(αSMA、I型胶原和纤连蛋白),FPS-ZM1或阿泽利拉贡共处理可抑制这些变化。
- FPS-ZM1阻断转化生长因子-β2诱导的Smad2依赖性信号通路和上皮-间质转化,而不影响细胞外信号调节激酶通路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Subretinal fibrosis, a complication of neovascular age-related macular degeneration (nAMD), involves the epithelial-mesenchymal transition (EMT) of retinal pigment epithelium (RPE) cells as a contributing mechanism. The receptor for advanced glycation end products (RAGE) is a multiligand receptor implicated in fibrotic diseases, but its role in subretinal fibrosis has not been studied. This study investigated the role of RAGE in subretinal fibrosis. METHODS: Subretinal fibrosis was induced in male RAGE-/- and wild-type (WT) mice via laser photocoagulation, and fibrosis lesion volume was assessed on day 35 using optical coherence tomography and immunostaining. In vitro, EMT was induced in primary human RPE cells with transforming growth factor-beta 2 (TGF-β2). The role of RAGE in EMT was studied in cells pretreated with RAGE antagonists (FPS-ZM1 or azeliragon), followed by cotreatment with TGF-β2 for 48 hours. Signaling studies were conducted by pretreatment with FPS-ZM1 for 2 hours, cotreatment with TGF-β2 for 60 minutes, and subsequent immunoblot analysis. RESULTS: In RAGE-/- mice, subretinal fibrosis after laser-induced choroidal neovascularization was significantly reduced, with a smaller fibrosis volume, less inflammation, decreased activation of pSmad2, and reduced deposition of fibrotic markers (αSMA, collagen I) compared to WT mice. In vitro treatment with TGF-β2 in human RPE cells increased mitochondrial reactive oxygen species and upregulated EMT markers (αSMA, collagen I, and fibronectin), which were inhibited by cotreatment with FPS-ZM1 or azeliragon. FPS-ZM1 blocked TGF-β2-induced Smad2-dependent signaling and EMT without affecting the extracellular signal-regulated kinase (ERK) pathway. CONCLUSIONS: Our findings indicate that RAGE plays a role in RPE cell EMT in subretinal fibrosis and that RAGE antagonists attenuate this process, making RAGE a promising therapeutic target for subretinal fibrosis in nAMD.
引用
- Sreekumar PG, Nam MH, Hong E, et al. RAGE Is Essential for Subretinal Fibrosis in Laser-Induced Choroidal Neovascularization: Therapeutic Implications. Invest Ophthalmol Vis Sci. 2025. PMID: 40488713. doi:10.1167/iovs.66.6.30
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。